160 related articles for article (PubMed ID: 28475508)
1. Primary Cutaneous Leiomyosarcoma Arising in a Patient With Li-Fraumeni Syndrome: A Neoplasm With Unusual Histopathologic Features and Loss of Heterozygosity at TP53 Gene.
Sabater-Marco V; Ferrando-Roca F; Morera-Faet A; García-García JA; Bosch SB; López-Guerrero JA
Am J Dermatopathol; 2018 Mar; 40(3):225-227. PubMed ID: 28475508
[No Abstract] [Full Text] [Related]
2. Rectal leiomyosarcoma as the initial phenotypic manifestation of Li-Fraumeni-like syndrome: a case report and review of the literature.
Severino NP; Waisberg J; Fragoso MCBV; de Lima LGCA; Balsamo F; Henriques AC; Bianco B; de Sousa Gehrke F
J Med Case Rep; 2022 Dec; 16(1):468. PubMed ID: 36529791
[TBL] [Abstract][Full Text] [Related]
3. Chest wall leiomyosarcoma after breast-conservative therapy for early-stage breast cancer in a young woman with Li-Fraumeni syndrome.
Henry E; Villalobos V; Million L; Jensen KC; West R; Ganjoo K; Lebensohn A; Ford JM; Telli ML
J Natl Compr Canc Netw; 2012 Aug; 10(8):939-42. PubMed ID: 22878818
[TBL] [Abstract][Full Text] [Related]
4. Multiple primary cutaneous melanomas in Li-Fraumeni syndrome.
Curiel-Lewandrowski C; Speetzen LS; Cranmer L; Warneke JA; Loescher LJ
Arch Dermatol; 2011 Feb; 147(2):248-50. PubMed ID: 21339461
[No Abstract] [Full Text] [Related]
5. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
[TBL] [Abstract][Full Text] [Related]
6. Atypical molecular background of glioblastoma and meningioma developed in a patient with Li-Fraumeni syndrome.
Rieske P; Zakrzewska M; Biernat W; Bartkowiak J; Zimmermann A; Liberski PP
J Neurooncol; 2005 Jan; 71(1):27-30. PubMed ID: 15719270
[TBL] [Abstract][Full Text] [Related]
7. High frequency of de novo mutations in Li-Fraumeni syndrome.
Gonzalez KD; Buzin CH; Noltner KA; Gu D; Li W; Malkin D; Sommer SS
J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618
[TBL] [Abstract][Full Text] [Related]
8. Li-Fraumeni syndrome presenting as cutaneous melanoma in a child: case report and review of literature.
Baek YS; Seo JY; Song JY; Lee SY; Kim A; Jeon J
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):e174-e175. PubMed ID: 30653764
[No Abstract] [Full Text] [Related]
9. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families.
Llovet P; Illana FJ; Martín-Morales L; de la Hoya M; Garre P; Ibañez-Royo MD; Pérez-Segura P; Caldés T; García-Barberán V
Fam Cancer; 2017 Oct; 16(4):567-575. PubMed ID: 28573494
[TBL] [Abstract][Full Text] [Related]
10. Atypical cutaneous melanocytic tumours arising in two patients with Li-Fraumeni syndrome.
Jacquemus J; Perron E; Pissaloux D; Alberti L; de la Fouchardière A
Pathology; 2017 Dec; 49(7):801-805. PubMed ID: 29108654
[No Abstract] [Full Text] [Related]
11. Identification and Management of
Pal T; Brzosowicz J; Valladares A; Wiesner GL; Laronga C
South Med J; 2017 Oct; 110(10):643-648. PubMed ID: 28973705
[TBL] [Abstract][Full Text] [Related]
12. Primary Axillary Vein Leiomyosarcoma in Li-Fraumeni Syndrome.
Roslly MZ; Omar N; Naim MS
Radiol Imaging Cancer; 2024 Jan; 6(1):e230184. PubMed ID: 38276907
[No Abstract] [Full Text] [Related]
13. Brain tumors in Li-Fraumeni syndrome: a commentary and a case of a gliosarcoma patient.
Guidi M; Giunti L; Lucchesi M; Scoccianti S; Giglio S; Favre C; Oliveri G; Sardi I
Future Oncol; 2017 Jan; 13(1):9-12. PubMed ID: 27523101
[No Abstract] [Full Text] [Related]
14. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
[TBL] [Abstract][Full Text] [Related]
15. The Li-Fraumeni syndrome: an inherited susceptibility to cancer.
Evans SC; Lozano G
Mol Med Today; 1997 Sep; 3(9):390-5. PubMed ID: 9302689
[TBL] [Abstract][Full Text] [Related]
16. Potential of Advexin: a p53 gene-replacement therapy in Li-Fraumeni syndrome.
Nemunaitis JM; Nemunaitis J
Future Oncol; 2008 Dec; 4(6):759-68. PubMed ID: 19086841
[TBL] [Abstract][Full Text] [Related]
17. Spectrum and Incidence of Skin Cancer among Individuals with Li-Fraumeni Syndrome.
Hatton JN; Sargen MR; Frone MN; de Andrade KC; Savage SA; Khincha PP
J Invest Dermatol; 2022 Sep; 142(9):2534-2537.e1. PubMed ID: 35183552
[No Abstract] [Full Text] [Related]
18. EGFR-mutated lung cancer in Li-Fraumeni syndrome.
Michalarea V; Calcasola M; Cane P; Tobal K; Izatt L; Spicer J
Lung Cancer; 2014 Sep; 85(3):485-7. PubMed ID: 25047674
[TBL] [Abstract][Full Text] [Related]
19. Li-Fraumeni syndrome.
Ossa CA; Molina G; Cock-Rada AM
Biomedica; 2016 Jun; 36(2):182-7. PubMed ID: 27622479
[TBL] [Abstract][Full Text] [Related]
20. Pilot study of the prevalence of autoimmune disorders in Li-Fraumeni syndrome.
Obregón IH; de Andrade KC; Bremer RC; Khincha PP; Savage SA
Fam Cancer; 2023 Jul; 22(3):319-321. PubMed ID: 36627407
[No Abstract] [Full Text] [Related]
[Next] [New Search]
